Avalo Therapeutics, Inc. ( NASDAQ:AVTX – Get Rating ) CEO Garry Arthur Neil purchased 4,000 shares of the business's stock in a transaction on Friday, June 9th. The stock was purchased at an average price of $3.42 per share, for a total transaction of $13,680.00. Following the acquisition, the chief executive officer now owns 13,220 shares of the company's stock, valued at approximately $45,212.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink .

https://www.dailypolitical.com/2023/06/13/avalo-therapeutics-inc-nasdaqavtx-ceo-garry-arthur-neil-buys-4000-shares.html

#dailypolitical